J Clin Oncol 21:2787–2799PubMedCrossRef 130 Klein S, Levitzki A

J Clin Oncol 21:2787–2799PubMedCrossRef 130. Klein S, Levitzki A (2009) Targeting the EGFR and the PKB pathway in cancer. Curr Opin Cell Biol 21:185–193PubMedCrossRef

131. Linger RM, Keating AK, Earp HS et al (2008) TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35–83PubMedCrossRef 132. Ashkenazi A (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19:325–331PubMedCrossRef 133. Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRef 134. Witz IP, Levy-Nissenbaum AZD1390 clinical trial O (2006) The tumor microenvironment in the post-PAGET era. Cancer Lett. 242:1–10PubMedCrossRef 135. Witz IP (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100:203–229PubMedCrossRef 136. Murphy G (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 8:929–941PubMedCrossRef

137. Hu M, Polyak K (2008) Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 44:2760–2765PubMedCrossRef 138. Hanna E, Quick J, Libutti SK (2009) The tumour microenvironment: a novel target for cancer therapy. Oral Dis 15:8–17PubMedCrossRef 139. Lorusso G, Rüegg C (2008) The tumor microenvironment and its Selleckchem BLZ945 contribution to tumor evolution toward metastasis. Histochem Cell Biol 130:1091–1103PubMedCrossRef 140. Shojaei F, Ferrara N (2008) Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Drug Resist Updat 11:219–230PubMedCrossRef 141. Whiteside TL (2008)

The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904–5912PubMedCrossRef 142. Wikman H, Vessella R, Pantel K (2008) Cancer micrometastasis and tumour dormancy. APMIS 116:754–770PubMedCrossRef 143. Rademakers SE, Span PN, Kaanders JH et al (2008) Molecular aspects of tumour hypoxia. Mol RANTES Oncol 2:41–53PubMedCrossRef 144. Mendoza M, Khanna C (2009) Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41:1452–1462PubMedCrossRef 145. Melnikova VO, Bar-Eli M (2009) Inflammation and melanoma metastasis. Pigment Cell Melanoma Res 22:257–267PubMedCrossRef 146. Klymkowsky MW, Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am J Pathol 174:1588–1593PubMedCrossRef 147. Joyce JA, Pollard JW (2009) STI571 manufacturer Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239–252PubMedCrossRef 148. Richmond A, Yang J, Su Y (2009) The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res 22:175–186PubMedCrossRef 149. Anton K, Glod J (2009) Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 10:185–191PubMedCrossRef 150.

Comments are closed.